- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Primary biliary cholangitis (PBC)
- Meeting Date: March 2021
- Public Summary Document (PSD) March 2021 PBAC Meeting - (PDF 989KB)
- Public Summary Document (PSD) March 2021 PBAC Meeting - (Word 69KB)
Obeticholic acid – March 2021
Obeticholic acid: Tablet 5 mg, Tablet 10 mg; Ocaliva®
Last updated
2 July 2021